Stay updated on DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Sign up to get notified when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site revision indicator in the footer changed from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T00:41:24.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now presents the NCT03782064 study record, including its terminated status, treatment and eligibility details, study results, and record dates. It also includes information about data sharing and links to the study protocol and statistical analysis plan.
    Difference
    53%
    Check dated 2026-11-10T18:30:25.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T18:37:41.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The footer revision label advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:10:55.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T19:37:48.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message, replacing the study record content with an error page. This blocks access to the study details, contacts, and locations previously visible on the entry.
    Difference
    19%
    Check dated 2026-09-22T22:49:06.000Z thumbnail image

Stay in the know with updates to DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DC/Myeloma Fusion+Nivolumab in Relapsed MM Clinical Trial page.